Maynard Um
-
-
-
-
-
-
-
Oragenics (OGEN) Announces 1-for-30 Reverse Stock Split
-
-
-
-
-
-
-
Oragenics (OGEN) Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation
-
-
-
-
-
-
-
Oragenics (OGEN) Develops Automated Intranasal Device for Treating Concussed Patients
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

